Education
About Us
Working with TipRanks
Follow Us
Onconetix (ONCO)
NASDAQ:ONCO
Total Valuation
Onconetix has a market cap or net worth of $1.01M. The enterprise value is .
Market Cap$1.01M
Enterprise Value
Share Statistics
Onconetix has 14.55M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14.55M
Owned by Insiders8.96%
Owned by Instutions0.25%
Financial Efficiency
Onconetix’s return on equity (ROE) is -0.64 and return on invested capital (ROIC) is -44.97%.
Return on Equity (ROE)-63.80%
Return on Assets (ROA)-42.75%
Return on Invested Capital (ROIC)-44.97%
Return on Capital Employed (ROCE)-51.24%
Revenue Per Employee$155,883.75
Profits Per Employee-$4,300,296.083
Employee Count12
Asset Turnover<0.01
Inventory Turnover3.26
Valuation Ratios
The current PE Ratio of Onconetix is -3.62. Onconetix’s PEG ratio is -0.04.
PE Ratio-3.62
PS Ratio2.32K
PB Ratio2.31
Price to Fair Value2.31
Price to FCF-9.94
Price to Operating Cash Flow-9.98
PEG Ratio-0.04
Income Statement
In the last 12 months, Onconetix had revenue of $1.87M and earned -$51.60M in profits. Earnings per share was -$5.07.
Revenue$1.87M
Gross Profit-$771.15K
Operating Income-$25.25M
Pretax Income-$51.74M
Net Income-$51.60M
EBITDA-49.74M
Earnings Per Share (EPS)-5.07
Cash Flow
In the last 12 months, operating cash flow was -$13.89M and capital expenditures $6.06M, giving a free cash flow of -$7.83M billion.
Operating Cash Flow-$13.89M
Free Cash Flow-$7.83M
Free Cash Flow per Share-$0.54
Dividends & Yields
Onconetix pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-10.06%
Earnings Yield-27.60%
Stock Price Statistics
Beta2.17
52-Week Price Change-98.80%
50-Day Moving Average0.25
200-Day Moving Average2.73
Relative Strength Index (RSI)21.39
Average Volume (3m)13.13M
Important Dates
Onconetix upcoming earnings date is May 10, 2024, After Close.
Last Earnings DateMar 7, 2024
Next Earnings DateMay 10, 2024
Ex-Dividend Date―
Financial Position
Onconetix as a current ratio of 0.34, with Debt / Equity ratio of 0.17
Current Ratio0.34
Quick Ratio0.32
Debt to Market Cap0.07
Net Debt to EBITDA-0.15
Interest Coverage Ratio-53.65
Taxes
In the past 12 months, Onconetix has paid -$139.78K in taxes.
Income Tax-$139.78K
Effective Tax Rate0.03%
Enterprise Valuation
Onconetix EV to EBITDA ratio is -3.84, with an EV/FCF ratio of -10.33.
EV to Sales2.41K
EV to EBITDA-3.84
EV to Free Cash Flow-10.33
EV to Operating Cash Flow-10.37
Balance Sheet
Onconetix has $341.50K in cash and marketable securities with $10.00M in debt, giving a net cash position of $9.66M billion.
Cash & Marketable Securities$341.50K
Total Debt$10.00M
Net Cash$9.66M
Net Cash Per Share$0.66
Tangible Book Value Per Share-$0.98
Margins
Gross margin is -1927.93%, with operating margin of -61634.47%, and net profit margin of -63986.48%.
Gross Margin-1927.93%
Operating Margin-61634.47%
Pretax Margin-64008.02%
Net Profit Margin-63986.48%
EBITDA Margin-62784.10%
EBIT Margin-62859.25%
Analyst Forecast
The average price target for Onconetix is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast-97.16%